Abstract

Typhoid fever has remained endemic and a major health problem in developing countries like Kenya due to poor sanitation, overcrowding and limited access to diagnostic services. The main aim of this study was to determine the diagnostic value of TUBEX ® TF IGM antibody tests for early diagnosis of typhoid fever among hospitalized patients in Nairobi County. TUBEX ® TF is a competitive immunoassay which detects presence of anti-09 IgM Salmonella Typhi antibodies in a patient’s serum. We studied TUBEX ® TF a rapid sera diagnostic test for its usefulness in early diagnosis of typhoid fever and we compared its sensitivity and specificity to that of Widal test. The study was conducted on 92 (Gp-I) febrile patients who had clinically suggestive signs and symptoms of typhoid fever. Two groups of controls were created; 45 (Gp-II) and 15 (Gp-III) age and sex matched febrile and healthy controls, respectively. Blood culture was performed in all cases while TUBEX ® TF and Widal tests were performed in both cases and controls. The sample size was based on convenience at the two health facilities of our study. Gp-I had 9 (9.78%) blood culture positives for S. Typhi, 11(11.99%) were positive for TUBEX ® TF while 17 (18.48%) were positive for Widal test. 3 (6.67%) Gp-II were positive on both TUBEX ® TF and Widal test while none of the two tests tested positive on Gp-III. Among 9 culture positive cases, TUBEX ® TF was positive in 8 cases same as Widal test with sensitivity, specificity, PPV and NPV values of 88.9% (95% CI: 51.18-99.7), 97.6% (95% CI: 91.6-99.7), 80.0 %(95% CI: 44.4-97.5), 98.8 %(95% CI: 93.4-100), respectively. Widal test had 88.89% (95% CI: 51.8-99.7), 90.4% (95% CI: 81.9-95.7), 50.00% (95% CI: 24.7-75.3), 98.7% (95% CI: 92.9-100) respectively. This study demonstrated better results with TUBEX ® TF test compared to Widal test when blood culture was used as a gold standard. However, these results should be further confirmed by using multiple gold standard tests such as molecular and enzyme-linked immunosorbent assays and carried out on large scale cross-sectional studies with varied prevalence of typhoid fever in the population. Keywords : Typhoid fever, TUBEX ® TF, Widal, Cases and Controls. DOI : 10.7176/JBAH/9-4-08

Highlights

  • Enteric fever, an infection caused by Salmonella enterica serovar Typhi and serovar Paratyphi A remains a major public health challenge

  • Widal test has been one of these diagnostic tests and it has been in use for over a century in developing countries, but has remained a sera diagnostic test with limited diagnostic utility due to low sensitivity, specificity and positive predictive values which changes with geographical areas (Sherwal et al, 2004)

  • This study strongly support continued evaluation of performances of the new and old sera diagnostic tests to be done on regular basis

Read more

Summary

Introduction

An infection caused by Salmonella enterica serovar Typhi and serovar Paratyphi A remains a major public health challenge. In Africa, Crump et al, 2004 estimates incidence of typhoid infections of 10-100 cases/100, 000 person years in most African countries, with the incidence highest in childhood. The use of Widal test has strengthened this concern for it is the rapid test mostly performed in most primary health settings and inability of these settings to perform blood culture (Willke et al, 2002). This is because the frequent use of Widal test is unlikely to be helpful but can be misleading resulting to misdiagnosis and worsening antibiotic resistance (Mweu et al, 2008). There have been few attempts to establish simple clinical case definitions for typhoid fever to help in case identification at presentation to health facilities (Tam et al, 2003)

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call